EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression

Nikola Balic iD, Gordana Nedic Erjavec iD, Marcela Konjevod, Jorge Saiz, Tina Curkovic, Lucija Tudor, Dubravka Svob Strac iD, Alja Videtic Paska iD, Julija Smon iD, Magda Tusek-Znidaric, Marina Sagud iD, Bjanka Vuksan Cusa und 6 weitere

Biomolecules · 2026

DOI: 10.3390/biom16040533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Nikola Balic und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Metabolomics, Metabolome, Extracellular Vesicles, Major Depressive Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, The Slovenian Research and Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is associated with complex metabolic alterations. In this study, we applied a multiplatform metabolomics approach (GC-MS and LC-MS) to characterize the plasma extracellular vesicle (EV) metabolome in healthy controls (N = 50), responsive MDD patients (N = 60), and patients with treatment-resistant depression (TRD; N = 65). Longitudinal analyses were performed following 8-week treatment with duloxetine (N = 30), bright-light therapy (BLT; N = 30), or esketamine (N = 35). A total of 230 metabolites were identified, with the most pronounced metabolic alterations observed in TRD patients, particularly in lipid, amino acid, and energy metabolism pathways. Elevated lysophospholipids and fatty acids in TRD suggested dysregulated lipid metabolism and inflammatory processes. All treatments resulted in clinical improvement, accompanied by partial normalization of metabolic profiles. Duloxetine treatment was associated with modulation of amino acid and glycerophospholipid metabolism, including increases in tryptophan-related metabolites and normalization of specific lipid species. BLT primarily reduced lysophospholipids and mannose levels, while esketamine modulated metabolites related to lipid turnover, short-chain fatty acids, carbohydrate metabolism, and neuroendocrine function, including increased thyrotropin-releasing hormone levels. These findings support the concept that TRD represents a biologically distinct and more metabolically dysregulated subtype of depression and highlight EV-based metabolomics as a promising approach for elucidating disease and treatment mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsMetabolomeExtracellular VesiclesMajor Depressive DisorderDepressive Disorder, Treatment-ResistantHumansDuloxetine HydrochlorideFemaleMaleAdultAntidepressive AgentsMiddle AgedKetamine

Stichwörter der Autor:innen

MDDTRDbright-light therapyduloxetineesketamineextracellular vesiclesmetabolomicstreatment

Substanzen

Duloxetine HydrochlorideAntidepressive AgentsKetamine

Autor:innen und Institutionen

  • Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, Croatia.
  • Department of Food Science and Technology, College of Agriculture and Environmental Sciences, University of California, Davis, CA 95616, USA.
  • BCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain.
  • Institute for Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
  • National Institute of Biology Ljubljana, 1000 Ljubljana, Slovenia.
  • Department for Psychiatry and Psychological Medicine, University Hospital Center Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Nikola Balic, Gordana Nedic Erjavec, Dubravka Svob Strac, Alja Videtic Paska, Julija Smon, Marina Sagud, Zrinka Pesut, Matea Nikolac Perkovic

Förderung

  • Croatian Science Foundation
  • The Slovenian Research and Innovation Agency

Zitieren

APA

Balic, N., Nedic Erjavec, G., Konjevod, M., Saiz, J., Curkovic, T., Tudor, L., Svob Strac, D., Videtic Paska, A., Smon, J., Tusek-Znidaric, M., Sagud, M., Vuksan Cusa, B., Fabijanic, T., Pesut, Z., Kosanovic Rajacic, B., Bradas, Z., Pivac, N., & Nikolac Perkovic, M. (2026). Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression. Biomolecules. https://doi.org/10.3390/biom16040533

Vancouver

Balic N, Nedic Erjavec G, Konjevod M, Saiz J, Curkovic T, Tudor L, et al. Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression. Biomolecules. 2026. doi:10.3390/biom16040533

BibTeX
@article{Balic2026,
  author = {Balic, Nikola and Nedic Erjavec, Gordana and Konjevod, Marcela and Saiz, Jorge and Curkovic, Tina and Tudor, Lucija and Svob Strac, Dubravka and Videtic Paska, Alja and Smon, Julija and Tusek-Znidaric, Magda and Sagud, Marina and Vuksan Cusa, Bjanka and Fabijanic, Tea and Pesut, Zrinka and Kosanovic Rajacic, Biljana and Bradas, Zoran and Pivac, Nela and Nikolac Perkovic, Matea},
  title = {Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16040533}
}
Kostenlos starten →